Try
BECTON DICKINSON & CO
BDXUnited States
76 filed reports · 519 financial concepts · 2 earnings calls · 5 media appearances
Filed reports
76 reports · Jun 2016 to Jun 2026Each report counts once it has at least one extracted financial fact. Also extracted from these reports: 226 guidance figures.
| Report type | Reports | Facts | Periods |
|---|---|---|---|
| Current · 8-KSEC EDGAR | 35 | 228 | Dec 2017 to Jun 2026 |
| Quarterly · 10-QSEC EDGAR | 31 | 4,829 | Jun 2016 to Jun 2026 |
| Annual · 10-KSEC EDGAR | 10 | 5,800 | Sep 2016 to Sep 2025 |
Documents
| Period | Type | Period end | Published | Facts | Source |
|---|---|---|---|---|---|
| FY2026 Q3 | 8-K | Jun 30, 2026 | Aug 6, 2026 | 2 | Open |
| FY2026 Q3 | 10-Q | Jun 30, 2026 | Aug 6, 2026 | 399 | Open |
| FY2026 Q2 | 8-K | Mar 31, 2026 | May 7, 2026 | 2 | Open |
| FY2026 Q2 | 10-Q | Mar 31, 2026 | May 7, 2026 | 257 | Open |
| FY2026 Q1 | 8-K | Dec 31, 2025 | Feb 9, 2026 | 2 | Open |
| FY2026 Q1 | 10-Q | Dec 31, 2025 | Feb 9, 2026 | 283 | Open |
| FY2025 | 10-K | Sep 30, 2025 | Nov 25, 2025 | 1,043 | Open |
| FY2025 Q4 | 8-K | Sep 30, 2025 | Nov 6, 2025 | 2 | Open |
| FY2025 Q3 | 10-Q | Jun 30, 2025 | Aug 7, 2025 | 156 | Open |
| FY2025 Q3 | 8-K | Jun 30, 2025 | Aug 7, 2025 | 8 | Open |
| FY2025 Q2 | 10-Q | Mar 31, 2025 | May 1, 2025 | 144 | Open |
| FY2025 Q2 | 8-K | Mar 31, 2025 | May 1, 2025 | 8 | Open |
Financial data
519 concepts · 10,857 factsEach concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.
Financial467 concepts · 8,828 facts · Sep 2014 to Jun 2026
- Net income loss59 · Sep 2014 to Jun 2026
- Revenue59 · Sep 2014 to Jun 2026
- Cash and cash equivalents at carrying value58 · Sep 2014 to Jun 2026
- Amortization of intangible assets57 · Sep 2014 to Jun 2026
- Comprehensive income net of tax57 · Sep 2014 to Jun 2026
- Cost of goods and services sold (US GAAP)57 · Sep 2014 to Jun 2026
- Costs and expenses57 · Sep 2014 to Jun 2026
- Income tax expense benefit57 · Sep 2014 to Jun 2026
- Investment income interest57 · Sep 2014 to Jun 2026
- Operating income loss57 · Sep 2014 to Jun 2026
- Other comprehensive income loss foreign currency transaction and translation adjustment net of tax57 · Sep 2014 to Jun 2026
- Other comprehensive income loss net of tax57 · Sep 2014 to Jun 2026
- Other comprehensive income loss pension and other postretirement benefit plans adjustment net of tax57 · Sep 2014 to Jun 2026
- Other nonoperating income expense57 · Sep 2014 to Jun 2026
- Research and development expense57 · Sep 2014 to Jun 2026
- Selling general and administrative expense57 · Sep 2014 to Jun 2026
- Depreciation depletion and amortization56 · Sep 2014 to Jun 2026
- Payments for proceeds from other investing activities56 · Sep 2014 to Jun 2026
- Payments to acquire property plant and equipment56 · Sep 2014 to Jun 2026
- Proceeds from payments for other financing activities56 · Sep 2014 to Jun 2026
- Repayments of long term debt56 · Sep 2014 to Jun 2026
- Share based compensation56 · Sep 2014 to Jun 2026
- Accumulated other comprehensive income loss net of tax55 · Sep 2014 to Jun 2026
- Assets55 · Sep 2014 to Jun 2026
Segment23 concepts · 1,560 facts · Sep 2014 to Jun 2026
- Revenue550 · Sep 2014 to Jun 2026
- Goodwill153 · Sep 2015 to Jun 2026
- Goodwill foreign currency translation gain loss136 · Sep 2016 to Jun 2026
- Income loss from continuing operations before income taxes minority interest and income loss from equity method investments119 · Sep 2014 to Jun 2025
- Goodwill purchase accounting adjustments91 · Sep 2015 to Sep 2025
- Goodwill acquired during period76 · Sep 2015 to Sep 2025
- Depreciation depletion and amortization61 · Sep 2014 to Jun 2026
- Goodwill written off related to sale of business unit45 · Sep 2016 to Sep 2023
- Cost of goods and services sold (US GAAP)36 · Sep 2023 to Jun 2026
- Operating income loss36 · Sep 2023 to Jun 2026
- Other operating income expense net36 · Sep 2023 to Jun 2026
- Research and development expense36 · Sep 2023 to Jun 2026
- Selling general and administrative expense36 · Sep 2023 to Jun 2026
- Operating Segments35 · Sep 2023 to Jun 2026
- Payments to acquire property plant and equipment25 · Sep 2014 to Sep 2022
- Segment expenditure addition to long lived assets25 · Sep 2021 to Dec 2025
- Total Assets16 · Sep 2015 to Sep 2020
- Goodwill translation and purchase accounting adjustments12 · Sep 2015 to Jun 2017
- Life Sciences12 · Sep 2016 to Sep 2017
- Goodwill transfers9 · Jun 2018 to Sep 2018
- Inventory recall expense7 · Sep 2019 to Sep 2022
- Impairment of intangible assets excluding goodwill6 · Sep 2018 to Sep 2022
- Asset impairment charges2 · Sep 2018 to Sep 2020
Guidance20 concepts · 228 facts · Feb 2018 to Aug 2026
- Revenue Growth Guidance45 · Feb 2018 to Aug 2025
- EPS (Diluted) Guidance44 · Nov 2018 to Aug 2026
- Revenue Guidance30 · Nov 2021 to Aug 2025
- EPS (Diluted) Guidance (Adjusted (non-GAAP))22 · Feb 2018 to May 2024
- EPS (Diluted) Growth Guidance (Adjusted (non-GAAP))18 · Feb 2018 to May 2024
- EPS (Diluted) Growth Guidance (Adjusted, constant currency)14 · Feb 2018 to Nov 2023
- EPS (Diluted) Growth Guidance10 · Feb 2023 to Aug 2025
- Revenue Growth Guidance (Constant currency)10 · Feb 2018 to May 2024
- Revenue Growth Guidance (Comparable, currency-neutral)9 · Feb 2018 to Aug 2019
- Revenue Growth Guidance (Organic)6 · Nov 2023 to May 2024
- EPS (Diluted) Guidance (Adjusted, post-spin basis)2 · May 2022
- EPS (Diluted) Guidance (Adjusted, pre-spin basis)2 · May 2022
- Revenue Growth Guidance (base business, before the impact of the Surgical Instrumentation platform divestiture; Constant currency)2 · Aug 2023
- Revenue Growth Guidance (base business; Post-spin, currency-neutral)2 · May 2022
- Revenue Growth Guidance (base business; Pre-spin, currency-neutral)2 · May 2022
- Revenue Growth Guidance (base; Organic)2 · Aug 2023
- Revenue Growth Guidance (base revenue, adjusting for the impact of the Surgical Instrumentation platform divestiture; Constant currency)2 · Aug 2023
- Revenue Growth Guidance (Comparable)2 · Jan 2019
- Revenue Guidance (Post-spin basis)2 · May 2022
- Revenue Guidance (Pre-spin basis)2 · May 2022
Geography5 concepts · 205 facts · Sep 2014 to Jun 2026
- Revenue168 · Sep 2014 to Jun 2026
- Covington, Georgia EtO Litigation19 · Dec 2021 to Mar 2025
- Loss contingency number of plaintiffs12 · Dec 2022 to Mar 2025
- GEORGIA3 · Sep 2022 to Sep 2024
- United States3 · Sep 2022 to Sep 2025
Product4 concepts · 36 facts · Sep 2016 to Sep 2025
- Revenue20 · Mar 2017 to Sep 2019
- Selling general and administrative expense10 · Sep 2016 to Sep 2025
- Loss contingency loss in period4 · Dec 2024 to Sep 2025
- Income loss from continuing operations before income taxes minority interest and income loss from equity method investments2 · Mar 2017 to Jun 2017
Segments
1,801 factsFigures broken down by business line, region, product or another axis the company reports on.
Statement business segments13 members · 1,560 facts
- Life Sciences376 · Sep 2014 to Dec 2025
- Interventional369 · Sep 2016 to Jun 2026
- Medical365 · Sep 2014 to Sep 2025
- Life sciences92 · Sep 2015 to Dec 2025
- Medical90 · Sep 2015 to Sep 2025
- Interventional72 · Sep 2017 to Jun 2026
- Connected Care65 · Dec 2024 to Jun 2026
- Medical Essentials65 · Dec 2024 to Jun 2026
- Bio Pharma Systems53 · Dec 2024 to Jun 2026
- Bio pharma systems4 · Sep 2025 to Jun 2026
- Connected care4 · Sep 2025 to Jun 2026
- Medical essentials4 · Sep 2025 to Jun 2026
- Surgery1 · Jun 2019
Statement geographicalsrt:StatementGeographicalAxis10 members · 164 facts
- US50 · Sep 2016 to Jun 2026
- Non Us44 · Sep 2017 to Jun 2026
- GA29 · Dec 2021 to Mar 2025
- Asia10 · Sep 2016 to Sep 2025
- Others Country10 · Sep 2016 to Sep 2025
- EMEA7 · Sep 2019 to Sep 2025
- Europe5 · Sep 2016 to Sep 2020
- Gwinnett County Georgia5 · Sep 2022 to Jun 2023
- International Countries2 · Jun 2017 to Jun 2018
- Middle East And Africa2 · Sep 2019 to Sep 2020
Statement geographicalus-gaap:StatementGeographicalAxis8 members · 41 facts
- US16 · Sep 2014 to Mar 2018
- International Countries9 · Jun 2015 to Mar 2018
- Asia4 · Sep 2014 to Sep 2017
- Europe4 · Sep 2014 to Sep 2017
- Others Country4 · Sep 2014 to Sep 2017
- Others country2 · Sep 2019 to Sep 2020
- Us1 · Sep 2020
- Asia1 · Sep 2020
Product or servicesrt:ProductOrServiceAxis5 members · 34 facts
- Interventional Specialties Brachytherapyand Feeding Products12 · Sep 2018 to Sep 2019
- Shipping And Handling10 · Sep 2016 to Sep 2025
- IV Fluids6 · Sep 2018 to Sep 2019
- Pyxis4 · Dec 2024 to Sep 2025
- Surgical Infection Prevention Drainage Products2 · Jun 2017
Product or serviceus-gaap:ProductOrServiceAxis1 member · 2 facts
- Surgical Infection Prevention Drainage Products2 · Mar 2017
Text from filings
Management commentary and risk factors, extracted from SEC filings only.
- Earnings-release commentary130 claims from 10 reports · Sep 2024 to Jun 2026
- Management discussion (MD&A) commentary227 claims from 8 reports · Sep 2024 to Jun 2026
- Risk-factor changes15 claims from 1 reports · Sep 2025
- Risk factors47 risks from 2 annual reports · 2024 to 2025
Earnings calls
2 calls · May 2026 to Aug 2026Transcripts with management claims and analyst questions, one per fiscal period.
- FY2026 Q3Aug 6, 2026
- FY2026 Q2May 7, 2026
Executive media
5 appearancesPodcasts, interviews and conference appearances by the company's executives, with their claims.
- Other appearances4 · Jan 2020 to Aug 2024
- TV interviews1 · Apr 2020
Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Oct 16, 2026) and refreshed every few hours.